Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia

Details for Australian Patent Application No. 2012202556 (hide)

Owner Board Of Regents, The University Of Texas System

Inventors Matalon, Ofer; Matalon, Reuben

Agent Fisher Adams Kelly

Pub. Number AU-A-2012202556

Parent 2005259961

Filing date 2 May 2012

Wipo publication date 24 May 2012

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/52 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

Event Publications

17 May 2012 Complete Application Filed

24 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202556

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202557-Versatile Kinetic Energy Recovery Device

2012202555-Quaternary Photodetector for downhole optical sensing